Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > what's happening with

<< Previous

Bullboard Posts

Next >>

Comment by Alba1314on Nov 21, 2018 10:29am

45 Views

Post# 29004296

RE:RE:RE:what's happening with

juansito wrote: lets see, I hope u wrong...

Why would you even consider that he may be right?? Has given zero reasons to support his statement. It's all just BS guessing. At the end of the day, if this closes above $0.06, it's not he's going to come back and say "I was wrong". BS posts like this shouldn't be given any attention.

<< Previous

Bullboard Posts

Next >>

Morning Market Outlook for Nov. 14, 2024